blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4021433

EP4021433 - TREATMENT OF MENSTRUAL CYCLE-INDUCED SYMPTOMS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  01.09.2023
Database last updated on 10.07.2024
FormerGrant of patent is intended
Status updated on  10.04.2023
FormerRequest for examination was made
Status updated on  03.06.2022
FormerThe international publication has been made
Status updated on  05.03.2021
Formerunknown
Status updated on  25.09.2020
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting statepublished on 26.06.2024  [2024/26]
Applicant(s)For all designated states
Period Pill BV
Nes 116
1012 KE Amsterdam / NL
[2022/27]
Inventor(s)01 / JANSSEN, Merel
Rijksstraatweg 163
1396 JK Baambrugge / NL
02 / JANSSEN, Edgar Stijn Jochem
Rijksstraatweg 163
1396 JK Baambrugge / NL
03 / GOLAN, Ezekiel
1120 Ironwork Passage, False Creek
Vancouver, British Columbia V6H 3P1 / CA
 [2022/27]
Representative(s)Michalski Hüttermann & Partner Patentanwälte mbB
Kaistraße 16A
40221 Düsseldorf / DE
[2022/27]
Application number, filing date20772102.826.08.2020
[2022/27]
WO2020IB57967
Priority number, dateUS201962891438P26.08.2019         Original published format: US 201962891438 P
[2022/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021038460
Date:04.03.2021
Language:EN
[2021/09]
Type: A1 Application with search report 
No.:EP4021433
Date:06.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 04.03.2021 takes the place of the publication of the European patent application.
[2022/27]
Type: B1 Patent specification 
No.:EP4021433
Date:04.10.2023
Language:EN
[2023/40]
Search report(s)International search report - published on:EP04.03.2021
ClassificationIPC:A61K31/137, A61P15/00, A61P25/00
[2022/27]
CPC:
A61K31/137 (EP,CN,IL,KR,US); A61P15/00 (EP,CN,IL,US); A61P15/02 (KR);
A61P25/00 (EP,CN,IL,KR)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/27]  
Extension statesBA24.03.2022
ME24.03.2022
Validation statesMA24.03.2022
TitleGerman:BEHANDLUNG VON MENSTRUATIONSZYKLUSINDUZIERTEN SYMPTOMEN[2022/27]
English:TREATMENT OF MENSTRUAL CYCLE-INDUCED SYMPTOMS[2022/27]
French:TRAITEMENT DE SYMPTÔMES INDUITS PAR LE CYCLE MENSTRUEL[2022/27]
Entry into regional phase24.03.2022National basic fee paid 
24.03.2022Designation fee(s) paid 
24.03.2022Examination fee paid 
Examination procedure24.03.2022Amendment by applicant (claims and/or description)
24.03.2022Examination requested  [2022/27]
24.03.2022Date on which the examining division has become responsible
11.04.2023Communication of intention to grant the patent
21.08.2023Fee for grant paid
21.08.2023Fee for publishing/printing paid
21.08.2023Receipt of the translation of the claim(s)
Fees paidRenewal fee
25.08.2022Renewal fee patent year 03
25.08.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipRS04.10.2023
[2024/26]
Cited inInternational search[A]WO2005049088  (NOVARTIS AG [CH], et al) [A] 1-35 * the whole document * * page 18, paragraph 2; claim 6 *;
 [A]WO2013171146  (LOHMANN THERAPIE SYST LTS [DE]) [A] 1-35 * the whole document ** claims 6,31 *;
 [AD]WO2019026019  (THERAPEUTIC ADJUNCTS INC [CA], et al) [AD] 1-35 * the whole document * * claims 1-19 *
by applicantUS2004048919
 US2004127409
 US2006241172
 US2006241176
 US2007098819
 US2007203078
 US2007255278
 US2008160083
 US2008262071
 US2010172916
 US2011207718
 US2013171269
 US2014356424
 US2016000815
 US2016058428
 US2016367614
 WO2019026019
 US2019099399
    - SCHOEP et al., Am J Obs Gyn, (20190000), vol. 220, page 569
    - DANFORTH et al., Prog Neuro-Psych and Biol Psych, (20160000), vol. 64, pages 237 - 249
    - AMOROSO et al., J. Psychopharm, (20160000), vol. 30, pages 595 - 600
    - FINGL et al., The Pharmacological Basis of Therapeutics, Mack Publishing Co., (19750000), page 1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.